Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 625 of 1048 entries
View as:

Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase: N/A Priority: Normal
NCT ID: NCT00910117 Org: User:
Start: 05/31/09 End: 12/31/11 Due: 12/31/12

Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC)

Phase: N/A Priority: Normal
NCT ID: NCT00629148 Org: User:
Start: 08/31/07 End: 12/31/10 Due: 12/31/11

Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004)

Phase: N/A Priority: Normal
NCT ID: NCT05281003 Org: User:
Start: 02/20/23 End: 09/01/26 Due: 09/01/27

Tislelizumab Plus GX Versus Tislelizumab Plus GP in the Treatment of R/M NPC

Phase: N/A Priority: Normal
NCT ID: NCT06177301 Org: User:
Start: 12/01/23 End: 12/31/27 Due: 12/31/28

A Cohort Study in Newly Diagnosed MZL

Phase: N/A Priority: Normal
NCT ID: NCT06449885 Org: User:
Start: 05/30/24 End: 06/30/34 Due: 06/30/35

Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03799679 Org: User:
Start: 11/26/18 End: 02/01/20 Due: 02/01/21

PLD and IFO As First-line Treatment for Patients With Advanced or Metastatic STS

Phase: N/A Priority: Normal
NCT ID: NCT03268772 Org: User:
Start: 04/01/15 End: 12/30/20 Due: 12/30/21

Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06999252 Org: User:
Start: 07/01/25 End: 06/01/29 Due: 06/01/30

A Study of Comparing Huachansu Plus Thoracic RT Versus RT Alone For ESCC

Phase: N/A Priority: Normal
NCT ID: NCT02647125 Org: User:
Start: 09/30/15 End: 12/31/22 Due: 12/31/23

Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)

Phase: N/A Priority: Normal
NCT ID: NCT04519905 Org: User:
Start: 01/06/20 End: 12/31/27 Due: 12/31/28

Cnidium Monnieri Detoxification Formula for Persistent High-risk Human Papillomavirus Infection of Cervix.

Phase: N/A Priority: Normal
NCT ID: NCT06705322 Org: User:
Start: 12/01/24 End: 03/27/27 Due: 03/27/28

A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection

Phase: N/A Priority: Normal
NCT ID: NCT06166147 Org: User:
Start: 12/18/23 End: 03/31/27 Due: 03/31/28

Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients with Locally Advanced or Metastatic Gallbladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06591650 Org: User:
Start: 09/10/24 End: 09/15/27 Due: 09/15/28

Impact on Quality of Life in Patients Undergoing Total Gastrectomy or Proximal Gastrectomy for Adenocarcinoma of Esophagogastric Junction

Phase: N/A Priority: Normal
NCT ID: NCT01697917 Org: User:
Start: 05/31/12 End: 05/31/17 Due: 05/31/18

The Effect of Cap-assisted Water Exchange Colonoscopy on Straight Passage of the Colonoscope Through the Sigmoid Colon, Without Loop Formation

Phase: N/A Priority: Normal
NCT ID: NCT06992856 Org: User:
Start: 06/01/25 End: 06/01/26 Due: 06/01/27

Zimberelimab Plus Metformin for Recurrent Ovarian Clear Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05759312 Org: User:
Start: 03/31/23 End: 02/28/25 Due: 02/28/26

A Randomized, Open-label, Multi-center Phase III Study Comparing the Efficacy of Oral Chemotherapy Combined With Trastuzumab Versus Paclitaxel Combined With Trastuzumab in the Adjuvant Treatment of HER2-positive, Lymph Node-negative Early Breast Cancer Patients(ORCHID-PLUS)

Phase: N/A Priority: Normal
NCT ID: NCT06992882 Org: User:
Start: 06/01/25 End: 06/10/30 Due: 06/10/31

Evaluation for the Effectiveness and Safety of Cryo-ablation in the Treatment of Early Invasive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04334785 Org: User:
Start: 05/01/20 End: 05/01/25 Due: 05/01/26

Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After Treatment With Basal Insulin

Phase: N/A Priority: Normal
NCT ID: NCT01310452 Org: User:
Start: 01/31/11 End: - Due: -

A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China

Phase: N/A Priority: Normal
NCT ID: NCT06591039 Org: User:
Start: 07/01/22 End: 12/31/25 Due: 12/31/26

Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06601283 Org: User:
Start: 11/22/24 End: 11/22/27 Due: 11/22/28

Efficacy and Safety of HAIC in Combination With TQB2868 and Ramucirumab for Second-line Treatment of Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06441019 Org: User:
Start: 07/01/24 End: 05/31/26 Due: 05/31/27

500mg Fulvestrant in HR+ MBC

Phase: N/A Priority: Normal
NCT ID: NCT03708432 Org: User:
Start: 07/15/17 End: 08/15/18 Due: 08/15/19

Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy

Phase: N/A Priority: Normal
NCT ID: NCT05674305 Org: User:
Start: 01/01/22 End: 01/01/27 Due: 01/01/28

Metronomic PLD in Patients With Primary Endocrine Resistant ABC

Phase: N/A Priority: Normal
NCT ID: NCT03071926 Org: User:
Start: 03/01/17 End: 12/01/22 Due: 12/01/23